Patients with sickle cell disease are often hesitant to undergo transformative gene therapy—the current lengthy process requires multiple hospital visits to collect enough stem cells. Researchers from ...

Emmecell, a clinical-stage biotechnology company developing magnetic cell delivery technologies for ophthalmic diseases, announced the successful closing of a strategic financing round. The financing ...

Scientists at UC San Francisco have developed a way to create cancer-fighting CAR-T cells directly inside the body, potentially avoiding the slow and extremely expensive process of removing, ...

“I think there’s not a lot of information as to what the process is for individuals who have questions about that,” explains Kerry Rogers, MD. Rogers walks through the therapy step by step, from ...

Research teams have created a versatile set of gene delivery systems that can reach different neural cell types in the human brain and spinal cord with exceptional accuracy. These delivery systems are ...

Autologous CD19 CAR T products (tisagenlecleucel, axicabtagene ciloleucel, lisocabtagene maraleucel, brexucabtagene autoleucel) show high response rates across ALL and NHL, now including second-line ...

Most cancer deaths are caused not by the initial tumor but by the spread of cancer cells to distant organs in the process called metastasis. Since it occurs at the cellular level, the earliest stages ...

BioCardia announces the granting of a patent in Japan for its innovative catheter technology, enhancing cell therapy delivery to the heart. BioCardia, Inc. announced the granting of Japanese Patent No ...